FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317387798> ?p ?o ?g. }

• W4317387798 abstract "Abstract Background Creatinine-based estimated glomerular filtration rate (eGFR CRE ) may overestimate kidney function in patients with cancer. Cystatin C-based eGFR (eGFR CYS ) is an alternative marker of kidney function. We investigated whether patients with an eGFR discrepancy, defined as eGFR CYS >30% lower than the concurrent eGFR CRE , had an increased risk of adverse events resulting from renally-cleared medications. Patients and Methods We conducted a cohort study of adult patients with cancer who had serum creatinine and cystatin C measured on the same day between May 2010 and January 2022 at two academic cancer centers in Boston, MA. The primary outcome was the incidence of each of the following medication-related adverse events: 1) supratherapeutic vancomycin levels (>30μg/mL); 2) trimethoprim-sulfamethoxazole-related hyperkalemia (>5.5mEq/L); 3) baclofen-induced neurotoxicity; and 4) supratherapeutic digoxin levels (>2.0ng/mL). Results 1988 patients with cancer had simultaneous eGFR CYS and eGFR CRE . The mean age was 66 years (SD±14), 965 (49%) were female, and 1555 (78%) were non-Hispanic white. eGFR discrepancy occurred in 579 patients (29%). Patients with eGFR discrepancy were more likely to experience medication-related adverse events compared to those without eGFR discrepancy: vancomycin levels >30μg/mL (24% vs. 10%, p=0.004), trimethoprim-sulfamethoxazole-related hyperkalemia (24% vs. 12%, p=0.013), baclofen-induced neurotoxicity (25% vs. 0%, p=0.13), and supratherapeutic digoxin levels (38% vs. 0%, p=0.03). The adjusted OR for vancomycin levels >30μg/mL was 2.30 (95% CI 1.05 – 5.51, p = 0.047). Conclusion Among patients with cancer with simultaneous assessment of eGFR CYS and eGFR CRE , medication-related adverse events occur more commonly in those with eGFR discrepancy. These findings underscore the importance of accurate assessment of kidney function and appropriate dosing of renally-cleared medications in patients with cancer." @default.
• W4317387798 created "2023-01-19" @default.
• W4317387798 creator A5048669465 @default.
• W4317387798 date "2023-01-18" @default.
• W4317387798 modified "2023-10-17" @default.
• W4317387798 title "Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR" @default.
• W4317387798 cites W1550111394 @default.
• W4317387798 cites W1555064954 @default.
• W4317387798 cites W1989919608 @default.
• W4317387798 cites W1994112911 @default.
• W4317387798 cites W1995980728 @default.
• W4317387798 cites W1997093364 @default.
• W4317387798 cites W2000162860 @default.
• W4317387798 cites W2003056396 @default.
• W4317387798 cites W2010070252 @default.
• W4317387798 cites W2010520337 @default.
• W4317387798 cites W2011312924 @default.
• W4317387798 cites W2042421076 @default.
• W4317387798 cites W2055864845 @default.
• W4317387798 cites W2057549362 @default.
• W4317387798 cites W2073742622 @default.
• W4317387798 cites W2076560497 @default.
• W4317387798 cites W2076565113 @default.
• W4317387798 cites W2091119375 @default.
• W4317387798 cites W2093159962 @default.
• W4317387798 cites W2099531681 @default.
• W4317387798 cites W2110135514 @default.
• W4317387798 cites W2113525844 @default.
• W4317387798 cites W2118625269 @default.
• W4317387798 cites W2123775770 @default.
• W4317387798 cites W2134718689 @default.
• W4317387798 cites W2139124680 @default.
• W4317387798 cites W2164360599 @default.
• W4317387798 cites W2213510512 @default.
• W4317387798 cites W2321909854 @default.
• W4317387798 cites W2580180489 @default.
• W4317387798 cites W2789079578 @default.
• W4317387798 cites W2793605394 @default.
• W4317387798 cites W2794311213 @default.
• W4317387798 cites W2901678603 @default.
• W4317387798 cites W2906861038 @default.
• W4317387798 cites W2911413417 @default.
• W4317387798 cites W2984413960 @default.
• W4317387798 cites W3012260518 @default.
• W4317387798 cites W3036916730 @default.
• W4317387798 cites W3045393138 @default.
• W4317387798 cites W3082648342 @default.
• W4317387798 cites W3089837271 @default.
• W4317387798 cites W3093930062 @default.
• W4317387798 cites W3095099370 @default.
• W4317387798 cites W3124720076 @default.
• W4317387798 cites W3137775641 @default.
• W4317387798 cites W3165327555 @default.
• W4317387798 cites W3173929599 @default.
• W4317387798 cites W3180043336 @default.
• W4317387798 cites W3200217233 @default.
• W4317387798 cites W4205134490 @default.
• W4317387798 cites W4205629872 @default.
• W4317387798 cites W4226390647 @default.
• W4317387798 cites W4283818285 @default.
• W4317387798 doi "https://doi.org/10.1101/2023.01.18.23284656" @default.
• W4317387798 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36711583" @default.
• W4317387798 hasPublicationYear "2023" @default.
• W4317387798 type Work @default.
• W4317387798 citedByCount "1" @default.
• W4317387798 countsByYear W43173877982023 @default.
• W4317387798 crossrefType "posted-content" @default.
• W4317387798 hasAuthorship W4317387798A5048669465 @default.
• W4317387798 hasBestOaLocation W43173877981 @default.
• W4317387798 hasConcept C121608353 @default.
• W4317387798 hasConcept C126322002 @default.
• W4317387798 hasConcept C126894567 @default.
• W4317387798 hasConcept C159641895 @default.
• W4317387798 hasConcept C197934379 @default.
• W4317387798 hasConcept C2778980435 @default.
• W4317387798 hasConcept C2779489039 @default.
• W4317387798 hasConcept C2779548226 @default.
• W4317387798 hasConcept C2780306776 @default.
• W4317387798 hasConcept C523546767 @default.
• W4317387798 hasConcept C54355233 @default.
• W4317387798 hasConcept C71924100 @default.
• W4317387798 hasConcept C86803240 @default.
• W4317387798 hasConcept C90924648 @default.
• W4317387798 hasConceptScore W4317387798C121608353 @default.
• W4317387798 hasConceptScore W4317387798C126322002 @default.
• W4317387798 hasConceptScore W4317387798C126894567 @default.
• W4317387798 hasConceptScore W4317387798C159641895 @default.
• W4317387798 hasConceptScore W4317387798C197934379 @default.
• W4317387798 hasConceptScore W4317387798C2778980435 @default.
• W4317387798 hasConceptScore W4317387798C2779489039 @default.
• W4317387798 hasConceptScore W4317387798C2779548226 @default.
• W4317387798 hasConceptScore W4317387798C2780306776 @default.
• W4317387798 hasConceptScore W4317387798C523546767 @default.
• W4317387798 hasConceptScore W4317387798C54355233 @default.
• W4317387798 hasConceptScore W4317387798C71924100 @default.
• W4317387798 hasConceptScore W4317387798C86803240 @default.
• W4317387798 hasConceptScore W4317387798C90924648 @default.
• W4317387798 hasLocation W43173877981 @default.
• W4317387798 hasLocation W43173877982 @default.
• W4317387798 hasLocation W43173877983 @default.

• next